Skip to main content

OPINION article

Front. Med.
Sec. Infectious Diseases: Pathogenesis and Therapy
Volume 11 - 2024 | doi: 10.3389/fmed.2024.1470004

Opinion: Shortcomings in the Cochrane review on zinc for the common cold (2024)

Provisionally accepted
Harri Hemilä Harri Hemilä 1*Elizabeth Chalker Elizabeth Chalker 2
  • 1 University of Helsinki, Helsinki, Finland
  • 2 Australian National University, Canberra, Australian Capital Territory, Australia

The final, formatted version of the article will be published soon.

    Keywords: adverse effects, Common Cold, Meta-analysis, Pharmacology, randomized controlled trials, Respiratory Tract Infections, Zinc Acetate, zinc lozenges

    Received: 24 Jul 2024; Accepted: 13 Sep 2024.

    Copyright: © 2024 Hemilä and Chalker. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Harri Hemilä, University of Helsinki, Helsinki, Finland

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.